Metaxalone
Product Images NDC 45865-161

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 45865-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

161 (45865 161)

Metaxalone Tablets 800 mg label, generic for Skelaxin, manufactured by Appco Pharma LLC. The label displays tablet description as pink, oval, and scored, with a quantity of 60 tablets. The label includes warnings about potential dizziness or drowsiness and advises avoiding alcohol, with directions to take tablets as directed by a physician. The label includes NDC 45865-0161-60 and distribution details from Medsource Pharmaceuticals.*

FDA Label Image

Figure 1 (Metaxalone Figure1)

A line graph depicting mean concentrations and standard deviations of Metaxalone in ng/mL over 12 hours following an 800 mg dose under fasted and fed conditions. Concentration is plotted on the vertical axis and time in hours on the horizontal axis, showing higher concentrations under fed conditions.*

FDA Label Image

Structure (Metaxalone Structure)

Chemical structure of metaxalone showing a benzene ring with methyl substituents attached to an ether linkage leading to a morpholine ring with a carbamate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.